Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Controlled Trial of The Safety and Efficacy of S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) in Reducing Serum Alpha-Fetoprotein (AFP) in Patients With Hepatitis C and Moderately Elevated AFP

NCT00513461 is registered in ClinicalTrials.gov with Chao Family Comprehensive Cancer Center as lead sponsor.

NCT NCT00513461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00513461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Controlled Trial of The Safety and Efficacy of S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) in Reducing Serum Alpha-Fetoprotein (AFP) in Patients With Hepatitis C and Moderately Elevated AFP
Lead sponsor
Chao Family Comprehensive Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
December 31, 2013
Enrollment
110 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adult primary liver cancer, hepatitis c infection